Daily BriefsUnited States

Daily Brief United States: Amer Sports , Steven Madden, Vanda Pharmaceuticals and more

In today’s briefing:

  • Amer Sports IPO: The Fundamentals, and How We See It?
  • Steve Madden (SHOO) – Sunday, Oct 15, 2023
  • Vanda Pharmaceuticals Inc. (VNDA) – Sunday, Oct 15, 2023


Amer Sports IPO: The Fundamentals, and How We See It?

By Osbert Tang, CFA

  • We consider the fundamentals of Amer Sports (AS US) attractive and are positive towards its business outlook. Profitability has surged with solid growth rates in revenue and margin.
  • Amer’s investment case lies in its multi-brand portfolio, niche, functional, and professional products, margin expansion/profitability improvement, and China growth prospects.
  • Since the proceeds will be used to repay shareholder loans, this will lower its interest burden and strengthen its financial position. Hence, the IPO should further boost its profitability.

Steve Madden (SHOO) – Sunday, Oct 15, 2023

By Value Investors Club

Key points (machine generated)

  • Steve Madden is considered a good investment opportunity due to its strong management team and attractive price.
  • The shoe industry has faced challenges, but Steve Madden is seen to have minimal downside risk due to its solid balance sheet and reasonable valuation.
  • Steve Madden’s focus on branded shoes also makes it an attractive acquisition target, and if it achieves estimated 2025 earnings of $3 per share, its stock price could potentially increase by 40%.

This article is sourced from an online content aggregator through publicly available sources and is displayed below for general informational purposes only. This article was originally published 3 months ago on Value Investors Club.


Vanda Pharmaceuticals Inc. (VNDA) – Sunday, Oct 15, 2023

By Value Investors Club

Key points (machine generated)

  • Vanda Pharmaceuticals has established revenue-generating drugs and a pipeline of potential candidates in development.
  • The company has a strong balance sheet with ample cash reserves, offering potential for investments or acquisitions.
  • Despite these positive traits, the market values Vanda as if its core business is worthless, presenting a potential investment opportunity with significant upside potential.

This article is sourced from an online content aggregator through publicly available sources and is displayed below for general informational purposes only. This article was originally published 3 months ago on Value Investors Club.


💡 Before it’s here, it’s on Smartkarma

Sign Up for Free

The Smartkarma Preview Pass is your entry to the Independent Investment Research Network

  • ✓ Unlimited Research Summaries
  • ✓ Personalised Alerts
  • ✓ Custom Watchlists
  • ✓ Company Data and News
  • ✓ Events & Webinars